Literature DB >> 6189938

Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.

R C Giles, G Nunez, C K Hurley, A Nunez-Roldan, R Winchester, P Stastny, J D Capra.   

Abstract

Monoclonal antibody IVD12 was used to isolate and characterize a human Ia molecule present on B cells that generally display DR4 or DR5 phenotypes. The specificity of binding of IVD12 to human peripheral blood B cells from 75 normal individuals and 19 homozygous human lymphoblastoid B cell lines was identical to the supertypic specificity MB3 previously defined. Furthermore, IVD12-reactivity was shown to segregate with HLA in three informative families. In each family, individuals positive for IVD12 binding were also positive for DR4 or DR5. Using IVD12, a molecule has been isolated from the homozygous cell line PRIESS (DR4/4) and has been shown by amino acid sequence analysis to be homologous to the murine I-A and human HLA-DS molecules. These findings suggest that the MB3 specificity is found on a molecule encoded by loci distinct from those loci which encode HLA-DR molecules. This molecule represents the third family of HLA-D region molecules isolated from the cell line PRIESS. Both HLA-DR and HLA-SB molecules from this cell line were previously shown by amino acid sequence analysis to be I-E-like but distinct from one another. Collectively, these data provide evidence that the HLA-D region contains at least six loci encoding distinct alpha and beta chains for the HLA-SB, HLA-DR, and HLA-DS molecules.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6189938      PMCID: PMC2187005          DOI: 10.1084/jem.157.5.1461

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

Review 1.  HLA-D region molecules restrict proliferative T cell responses to antigen.

Authors:  E Thorsby; E Berle; H Nousiainen
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

Review 2.  The genetic control of human Ia alloantigens: a three-loci model derived from the immunochemical analysis of 'supertypic' specificities.

Authors:  N Tanigaki; R Tosi
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

3.  Human B cell alloantigens: expression of MB and MT determinants.

Authors:  M L Markert; P Cresswell
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

4.  Molecular relationships of the human B cell alloantigens, MT2, MB3, MT4, and DR5.

Authors:  R W Karr; C C Kannapell; J A Stein; H M Gebel; D L Mann; R J Duquesnoy; T C Fuller; G E Rodey; B D Schwartz
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

5.  SB: a new HLA-linked human histocompatibility gene defined using HLA-mutant cell lines.

Authors:  P Kavathas; R DeMars; F H Bach; S Shaw
Journal:  Nature       Date:  1981-10-29       Impact factor: 49.962

6.  Two-dimensional gel analysis of the polypeptides precipitated by a polymorphic HLA-DR1,2,w6 monoclonal antibody: evidence for a third locus.

Authors:  T A De Kretser; M J Crumpton; J G Bodmer; W F Bodmer
Journal:  Eur J Immunol       Date:  1982-07       Impact factor: 5.532

Review 7.  HLA-DR antigens: structure, separation of subpopulations, gene cloning and function.

Authors:  D A Shackelford; J F Kaufman; A J Korman; J L Strominger
Journal:  Immunol Rev       Date:  1982       Impact factor: 12.988

8.  The human HLA-DR antigens are encoded by multiple beta-chain loci.

Authors:  C K Hurley; G Nunez; R Winchester; O J Finn; R Levy; J D Capra
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

9.  [Primary structure of class II human histocompatibility antigens. 1st communication. Amino acid sequence of the N-terminal 198 residues of the beta chain of a HLA-Dw2,2;DR2,2-alloantigen (author's transl)].

Authors:  H Kratzin; C Y Yang; H Götz; E Pauly; S Kölbel; G Egert; F P Thinnes; P Wernet; P Altevogt; N Hilschmann
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1981-12

10.  Biochemical characterization of a second family of human Ia molecules, HLA-DS, equivalent to murine I-A subregion molecules.

Authors:  S M Goyert; J E Shively; J Silver
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  32 in total

1.  T lymphocyte clones detecting novel supertypic HLA class II allospecificities.

Authors:  N Flomenberg; R W Knowles; D Williams; K Horibe; K Rosenkrantz; B Dupont
Journal:  Immunogenetics       Date:  1985       Impact factor: 2.846

2.  Serological discrimination of DR4 haplotypes by radioimmunoassay.

Authors:  N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

3.  Recognition of class II molecules by human T cells. I. Analysis of epitopes of DR and DQ molecules in a DRw11, DRw52, DQw3 haplotype.

Authors:  L K Myers; E J Ball; G Nuñez; P Stastny
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

4.  HLA-DQ2 and -DQ8 signatures of gluten T cell epitopes in celiac disease.

Authors:  Stig Tollefsen; Helene Arentz-Hansen; Burkhard Fleckenstein; Oyvind Molberg; Melinda Ráki; William W Kwok; Günther Jung; Knut E A Lundin; Ludvig M Sollid
Journal:  J Clin Invest       Date:  2006-07-27       Impact factor: 14.808

5.  Mutational analysis of the HLA-DQ3.2 insulin-dependent diabetes mellitus susceptibility gene.

Authors:  W W Kwok; C Lotshaw; E C Milner; N Knitter-Jack; G T Nepom
Journal:  Proc Natl Acad Sci U S A       Date:  1989-02       Impact factor: 11.205

6.  Southern blot and microfingerprinting analysis of two DR7 haplotypes.

Authors:  G Angelini; N Tanigaki; R Tosi; G B Ferrara
Journal:  Immunogenetics       Date:  1986       Impact factor: 2.846

7.  Differential expression of Ia antigens by rheumatoid synovial lining cells.

Authors:  G R Burmester; B Jahn; P Rohwer; J Zacher; R J Winchester; J R Kalden
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  Detection of a novel HLA-DQ specificity. II. Cellular analysis by cytotoxic T-cell clones.

Authors:  H Kojima; Y Fukasawa; N Ishikawa; Y Tajima; A Wakisaka; M Aizawa
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

9.  L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs.

Authors:  D S Monos; E Czanky; S J Ono; S F Radka; D Kappes; J L Strominger
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

10.  Identification of T-cell epitopes on E2 protein of rubella virus, as recognized by human T-cell lines and clones.

Authors:  D Ou; P Chong; Y Choi; P McVeigh; W A Jefferies; G Koloitis; A J Tingle; S Gillam
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.